Leptin promotes melanoma tumor growth in mice related to increasing circulating endothelial progenitor cells numbers and plasma NO production

Journal of Experimental and Clinical Cancer Research

Volumn 30, Issue 1, 2011, Pages

  Amjadi, Fatemehsadat ^a   Javanmard, Shaghaygh Haghjooy ^a   Zarkesh Esfahani, Hamid ^a   Khazaei, Majid ^a   Narimani, Manijeh ^a  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; LEPTIN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 9F8; NITRIC OXIDE; PHOSPHATE BUFFERED SALINE; RECOMBINANT LEPTIN; UNCLASSIFIED DRUG; LEPTIN RECEPTOR;

ANIMAL CELL; ANIMAL EUTHANASIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD SAMPLING; BODY WEIGHT; CELL COUNT; CELL PROLIFERATION; CIRCULATION; CONTROLLED STUDY; ENDOTHELIAL PROGENITOR CELL; INJECTION; MALE; MELANOMA; METABOLITE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR GROWTH; TUMOR VOLUME; ADIPOCYTE; ANIMAL; BLOOD; C57BL MOUSE; ENDOTHELIUM CELL; EXPERIMENTAL MELANOMA; METABOLISM; PATHOLOGY; SKIN TUMOR; STEM CELL;

ADIPOCYTES; ANIMALS; ENDOTHELIAL CELLS; LEPTIN; MALE; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; NITRIC OXIDE; RECEPTORS, LEPTIN; SKIN NEOPLASMS; STEM CELLS;

EID: 79951689120     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-30-21     Document Type: Article

References (44)

1. Angiogenesis in cancer, vascular, rheumatoidand other disease. J Folkman, Nat Med 1995 1 27 31 10.1038/nm0195-27 7584949
2. Alternative vascularization mechanisms in cancer: Pathology and therapeutic implications. B Dome MJ Hendrix S Paku J Tovari J Timar, Am J Pathol 2007 170 1 15 10.2353/ajpath.2007.060302 17200177 (Pubitemid 47339184)
3. Circulating endothelial precursor cells, mystery, reality and promise. S Rafii, J Clin Invest 2000 105 17 19 10.1172/JCI8774 10619857 (Pubitemid 30036383)
4. A mathematical model of the contribution of endothelialprogenitor cells to angiogenesis in tumors: implicationsforantiangiogenic therapy. BR Stoll C Migliorini A Kadambi LL Munn RK Jain, Blood 2003 102 7 2555 2561 10.1182/blood-2003-02-0365 12775571 (Pubitemid 37193595)
5. Multistep nature of microvascular recruitment of ex vivo-expanded embryonic endothelial progenitor cells during tumor angiogenesis. P Vajkoczy S Blum M Lamparter R Mailhammer R Erber B Engelhardt D Vestweber AK Hatzopoulos, J Exp Med 2003 197 12 1755 1765 10.1084/jem.20021659 12810693 (Pubitemid 36745350)
6. Impaired recruitment of bone marrow derivedendothelial and a hematopoietic precursor cells blocks tumor angiogenesis and growth. D Lyden K Hattori S Dias L Witte N Hackett R Crystal C Costa P Blakie L Butros A Chadburn B Heissig W Marks L Witte Y Wu D Hicklin Zh Zhu M Moore K Hajjar K Manova R Benezra Sh Raffii, Nat Med 2001 7 1194 1201 10.1038/nm1101-1194 11689883 (Pubitemid 33063774)
7. Leptin in humans: lessons from translational research. S Blüher CS Mantzoros, Am J ClinNutr 2009 89 3 991S 997S
8. Involvement of nitric oxide in endothelium-dependent arterial relaxation by leptin. K Kimura K Tsuda A Baba T Kawabe S Boh-oka M Ibata C Moriwaki T Hano I Nishio, BiochemBiophys Res Commun 2002 273 745 749 10.1006/bbrc.2000.3005
9. Leptin effect on endothelial nitric oxide is mediated through akt-endothelial nitric oxide synthase phosphorylation pathway. C Vecchione A Maffei S Colella A Aretini R Poulet G Frati M Gentile L Fratta B Trimarco G Lembo, Diabetes 2002 51 168 173 10.2337/diabetes.51.1.168 11756337 (Pubitemid 34517994)
10. Leptin signaling promotes the growth of mammary tumors and increases the expression of vascular endothelial growth factor (VEGF) and its receptor type two (VEGF-R2). RR Gonzalez S Cherfils M Escobar JH Yoo C Carino AK Styer BT Sullivan H Sakamoto A Olawaiye T Serikawa M Lynch Bo Rueda, J BiolChem 2006 281 26320 26328 (Pubitemid 44401840)
11. Angiogenic activity of leptin in the chick embryo chorioallantoic membrane is in partmediated by endogenous fibroblast growth factor-2. D Ribatti B Nico AS Belloni A Vacca L Roncali GG Nussdorfer, Int J Mol Med 2001 8 3 265 8 11494053
12. Leptin, the product ofOb gene, promotes angiogenesis. A Bouloumie HC Drexler M Lafontan R Busse, Circ Res 1998 83 1059 1066 9815153 (Pubitemid 28520935)
13. Biological action of leptin as anangiogenic factor. MR Sierra-Honigmann AK Nath C Murakami G Garcia-Cardena A Papapetropoulos WC Sessa LA Madge JS Schechner MB Schwabb PJ Polverini JR Flores-Riveros, Science 1998 281 1683 1686 10.1126/science.281.5383.1683 9733517 (Pubitemid 28435586)
14. Leptin can induce proliferation, differentiation, and functional activation of hemopoietic cells. T Gainsford TA Willson D Metcalf E Handman C McFarlane A Ng NA Nicola WS Alexander DJ Hilton, ProcNatlAcadSci USA 1996 93 14564 14568 10.1073/pnas.93.25.14564 (Pubitemid 26419007)
15. Leptin enhances the recruitment of endothelial progenitor cells into neointimal lesions after vascular injury by promoting integrin mediated adhesion. MR Schroeter M Leifheit P Sudholt NM Heida C Dellas I Rohm F Alves M Zientkowska S Rafail M Puls G Hasenfuss S Konstantinides K Schäfer, Circ Res 2008 103 536 544 10.1161/CIRCRESAHA.107.169375 18658052
16. Leptin receptor and functionaleffects of leptin in human endothelial progenitor cells. R Wolk A Deb NM Caplice VK Somers, Atherosclerosis 2005 183 131 139 10.1016/j.atherosclerosis.2005.03.048 15950978 (Pubitemid 41416831)
17. Leptin induces endothelial cell migration through Akt, which is inhibited by PPARgamma-ligands. S Goetze A Bungenstock C Czupalla F Eilers P Stawowy U Kintscher C Spencer-Hansch K Graf B Nurnberg RE Law E Fleck M Grafe, Hypertension 2002 40 748 754 10.1161/01.HYP.0000035522.63647.D3 12411472 (Pubitemid 35278614)
18. Endothelial effects of leptin: implications in health and diseases. K Rahmouni WG Haynes, CurrDiab Rep 2005 5 4 260 6 (Pubitemid 41269590)
19. Melanoma risk in association with serum leptin levels and lifestyle parameters: a case-control study. H Gogas M Trakatelli N Dessypris A Terzidis A Katsambas GP Chrousos ET Petridou, Ann Oncol 2008 19 384 9 10.1093/annonc/mdm464 17925285 (Pubitemid 351201725)
20. Obesity promotes melanoma tumor growth: role of leptin. EL Brandon JW Gu L Cantwell Z He G Wallace JE Hall, Cancer BiolTher 2009 8 19 1871 9 10.4161/cbt.8.19.9650
21. Identification of a monoclonal antibody against the leptin receptor that acts as an antagonist and blocks human monocyte and T cell activation. M Fazeli H Zarkesh-Esfahani Z Wu M Maamra M Bidlingmaier AG Pockley P Watson G Matarese CJ Strasburger RJ Ross, J Immunol Methods 2006 312 1-2 190 200 10.1016/j.jim.2006.03.011 16690078 (Pubitemid 44209011)
22. Quantification of circulating endothelial progenitor cells using the modified ISHAGE protocol. C Schmidt-Lucke S Fichtlscherer A Aicher C Tschöpe HP Schultheiss AM Zeiher S Dimmeler, PLoS One 2010 5 11 13790 10.1371/journal.pone.0013790 21072182
23. Effect of L-arginine on circulating endothelial progenitor cells in hypercholesterolemic rabbits. SH Javanmard Y Gheisari M Soleimani M Nematbakhsh A Monajemi, Int J Cardiol 2010 143 2 213 6 10.1016/j.ijcard.2008.11.203 19167766
24. Enhanced expression of leptin and leptin receptor (OB-R) in human breast cancer. M Ishikawa J Kitayama H Nagawa, Clin Cancer Res 2004 10 13 4325 31 10.1158/1078-0432.CCR-03-0749 15240518 (Pubitemid 38878870)
25. Overexpression of the obesity hormone leptin in human colorectal cancer. M Koda M Sulkowska L Kanczuga-Koda E Surmacz S Sulkowski, J ClinPathol 2007 60 8 902 6 (Pubitemid 47234437)
26. Leptin promotes invasiveness of murine renal cancer cells via extracellular signal-regulated kinases and rho dependent pathway. A Horiguchi M Sumitomo J Asakuma T Asano R Zheng T Asano DM Nanus M Hayakawa, J Urol 2006 176 4 Pt 1 1636 41 10.1016/j.juro.2006.06.040 16952706 (Pubitemid 44316854)
27. Expression of leptin, leptin receptor, and hypoxia-inducible factor 1 alpha in human endometrial cancer. M Koda M Sulkowska A Wincewicz L Kanczuga-Koda B Musiatowicz M Szymanska S Sulkowski, Ann N Y Acad Sci 2007 1095 90 8 10.1196/annals.1397.013 17404022 (Pubitemid 47092441)
28. Genetically obese MMTV-TGFalpha/Lep (ob) Lep (ob) female mice do not develop mammary tumors. MP Cleary FC Phillips SC Getzin TL Jacobson MK Jacobson TA Christensen Sc Juneja JP Grande NJ Maihle, Breast Cancer Res Treat 2003 77 205 15 10.1023/A:1021891825399 12602920 (Pubitemid 36197635)
29. Effect of high fat diet on body weight and mammary tumor latency in MMTV-TGF mice. MP Cleary JP Grande NJ Maihle, Int J ObesRelatMetabDisord 2004 28 956 62 10.1038/sj.ijo.0802664 (Pubitemid 38998699)
30. Leptin regulation of proangiogenic molecules in benign and cancerous endometrial cells. C Carino AB Olawaiye S Cherfils T Serikawa MP Lynch BR Rueda RR Gonzalez, Int J Cancer 2008 123 12 2782 90 10.1002/ijc.23887 18798554
31. Leptin-signaling inhibition results in efficient anti-tumor activity in estrogen receptor positive or negative breast cancer. R Gonzalez Rene A Watters Y Xu UP Singh DR Mann BR Rueda ML Penichet, Breast Cancer Res 2009 11 3 36 10.1186/bcr2321 19531256
32. Cellular and molecular crosstalk between leptin receptor and estrogen receptor-{alpha} in breast cancer: molecular basis for a novel therapeutic setting. R Fusco M Galgani C Procaccini R Franco G Pirozzi L Fucci P Laccetti G Matarese, Endocr Relat Cancer 2010 17 2 373 82 10.1677/ERC-09-0340 20410173
33. Obesity promotes 7,12 dimethylbenz (a) anthracene-induced mammary tumor development in female zucker rats. R Hakkak AW Holley SL Macleod PM Simpsom GJ Fuchs CH Jo Th Kieber-Emmons, Breast Cancer Res 2005 7 627 33 10.1186/bcr1263
34. Leptin-stimulated endothelial nitric-oxide synthase via an adenosine 5'-monophosphate-activated protein kinase/Akt signaling pathway is attenuated by interaction with C-reactive protein. C Procopio F Andreozzi E Laratta A Cassese F Beguinot F Arturi ML Hribal F Perticone G Sesti, Endocrinology 2009 150 8 3584 93 10.1210/en.2008-0921 19359389
35. Leptin and nitric oxide production in normotensive and hypertensive men. K Tsuda I Nishio, Obes Res 2004 12 8 1223 37 10.1038/oby.2004.154 15340103
36. Human leptin stimulates systemic nitric oxide production in the rat. J Beltowski G Wájcicka E Borkowska, Obes Res 2002 10 9 939 46 10.1038/oby.2002.128 12226143 (Pubitemid 135688908)
37. Resting and circadian release of nitric oxide is controlled by leptin in male rats. CA Mastronardi WH Yu SM McCann, Proc Natl Acad Sci USA 2002 99 8 5721 6 10.1073/pnas.082098499 11960027 (Pubitemid 34411617)
38. Leptin enhances the potency of circulating angiogenic cells via src kinase and integrin (alpha)vbeta5: implications for angiogenesis in human obesity. NM Heida M Leifheit-Nestler MR Schroeter JP Müller IF Cheng S Henkel A Limbourg FP Limbourg F Alves JP Quigley ZM Ruggeri G Hasenfuss S Konstantinides K Schäfer, Arterioscler ThrombVasc Biol 2010 30 2 200 6 10.1161/ATVBAHA.109.192807
39. The involvement of endothelial progenitorcells in tumor angiogenesis. D Rabitti, J Cell Mol Med 2004 8 294 300 10.1111/j.1582-4934.2004.tb00319.x 15491505
40. The role and therapeutic potential of endothelial progenitor cells in tumor neovascularization. B Janic AS Arbab, ScientificWorldJournal 2010 10 1088 99 20563532
41. Involvement of endothelial progenitor cells in tumor vascularization. A Patenaude J Parker A Karsan, Microvasc Res 2010 79 3 217 23 10.1016/j.mvr.2010. 01.007 20085777
42. Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells. A Aicher C Heeschen C Mildner-Rihm C Urbich C Ihling K Technau-Ihling AM Zeiher S Dimmeler, Nat Med 2003 9 11 1370 6 10.1038/nm948 14556003 (Pubitemid 37466185)
43. Role of endothelial nitric oxide in bone marrow-derived progenitor cell mobilization. MM de Resende LY Huw HS Qian K Kauser, HandbExpPharmacol 2007 180 37 44
44. Leptin receptor and functional effects of leptin in human endothelial progenitor cells. R Wolk A Deb NM Caplice VK Somers, Atherosclerosis 2005 183 1 131 9 10.1016/j.atherosclerosis.2005.03.048 15950978 (Pubitemid 41416831)